Letrozole is available under several brand names, with Femara being the most prominent. It is a prescription medication used primarily to treat hormone receptor-positive breast cancer in postmenopausal women [1].
What is Letrozole used for?
Letrozole is an aromatase inhibitor. It works by reducing the amount of estrogen produced by the body. For breast cancer patients, this is significant because estrogen can fuel the growth of hormone receptor-positive tumors [2]. It is used for:
* Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer [2].
* Extended adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer who have received prior standard adjuvant tamoxifen therapy [2].
* First-line treatment of postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer [2].
* Treatment of postmenopausal women with hormone receptor-positive advanced breast cancer who have received prior antiestrogen therapy [2].
* In some cases, it may be used off-label to induce ovulation in women with infertility [3].
Are there different brands of Letrozole?
Yes, while Femara is a well-known brand, generic versions of letrozole are also available. The availability of generic options often arises after patent protections for the original brand expire [4]. DrugPatentWatch.com tracks patent information for various medications, including letrozole [5].
When does the patent for Femara expire?
Patent expirations allow for the manufacturing of generic versions of a drug, which can lead to lower prices. Information on patent status and expiration dates for drugs like Femara can be found through resources like DrugPatentWatch.com [5].
What are the side effects of Letrozole?
Common side effects associated with letrozole can include hot flashes, joint pain (arthralgia), fatigue, nausea, and increased cholesterol levels [2]. Less common but more serious side effects can include bone thinning (osteoporosis) and an increased risk of blood clots or stroke [2]. Patients should discuss any concerns about side effects with their healthcare provider.
How does Letrozole compare to other breast cancer treatments?
Letrozole belongs to a class of drugs called aromatase inhibitors. Other aromatase inhibitors include anastrozole (Arimidex) and exemestane (Aromasin) [2]. These drugs are often compared based on their efficacy, side effect profiles, and impact on bone health. Tamoxifen, another common breast cancer medication, works differently by blocking estrogen's effects rather than reducing its production [2]. The choice of treatment depends on individual patient factors and the stage and type of breast cancer.
Can generic letrozole be used interchangeably with the brand name?
In many regions, generic drugs are approved by regulatory agencies, such as the U.S. Food and Drug Administration (FDA), and are considered therapeutically equivalent to their brand-name counterparts. This means they contain the same active ingredient, dosage form, strength, and route of administration and are expected to have the same clinical effect and safety profile [6]. However, patients should consult their doctor or pharmacist regarding any specific concerns about switching between brand-name and generic medications.
Sources:
[1] https://www.drugpatentwatch.com/medications/letrozole/
[2] https://www.drugpatentwatch.com/medications/femara/
[3] https://www.drugpatentwatch.com/medications/letrozole/off-label-uses
[4] https://www.drugpatentwatch.com/drug-monopoly-and-generic-entry-for-letrozole
[5] https://www.drugpatentwatch.com/
[6] https://www.fda.gov/about-fda/pharmaceuticals/generic-drugs